A Phase I Clinical Study on the Safety and Pharmacokinetics of [18F]Florbetazine Injection

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 6, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions

MCIAD

Interventions

DRUG

[18F]Florbetazine

Evaluate the safety of \[18F\]Florbetazine injection in AD and MCI patients, and healthy subjects.

Trial Locations (1)

Chinese PLA General Hospital, Beijing

All Listed Sponsors

lead

HTA Co., Ltd.

INDUSTRY

NCT06593626 - A Phase I Clinical Study on the Safety and Pharmacokinetics of [18F]Florbetazine Injection | Biotech Hunter | Biotech Hunter